Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q4 FY22 results · Jan–Mar 2022
Amrutanjan Health Care reported revenue from operations of ₹106.55 crore (up 13.3% from Q4 FY21) and net profit of ₹14.71 crore (up 43.8% from Q4 FY21) for Q4 FY22 (Jan–Mar 2022), on a standalone basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 106.55 | 94.02 | +13.3% | 110.70 | −3.7% |
| Other income | 5.16 | 2.68 | +92.5% | 3.20 | +61.3% |
| Total income | 111.71 | 96.70 | +15.5% | 113.89 | −1.9% |
| Profit before tax | 20.02 | 13.71 | +46.0% | 27.91 | −28.3% |
| Net profit for the period | 14.71 | 10.23 | +43.8% | 20.58 | −28.5% |
| EPS, basic (₹) | 5.09 | 3.50 | +45.4% | 7.05 | −27.8% |
| Net margin (%) | 13.8 | 10.9 | 18.6 |
Standalone
- Filed with BSE
- 03 Jun 2022, 12:26 IST
- Board meeting
- 24 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE